Accolade Stock Analysis

ACCD
 Stock
  

USD 12.91  1.18  10.06%   

The latest price surge of Accolade could raise concerns from shareholders as the firm is trading at a share price of 12.91 on 698,600 in volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.27. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Accolade partners.
Please continue to Trending Equities.
  
The Accolade stock analysis report makes it easy to digest most publicly released information about Accolade and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Accolade Stock analysis module also helps to analyze the Accolade price relationship with some important fundamental indicators such as market cap and management efficiency.

Accolade Stock Analysis Notes

About 82.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.06. Some equities with similar Price to Book (P/B) outperform the market in the long run. Accolade has Price/Earnings To Growth (PEG) ratio of 1.64. The entity recorded a loss per share of 2.65. The firm had not issued any dividends in recent years. Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people. For more info on Accolade please contact the company at 206 926 8100 or go to https://www.accolade.com.

Accolade Quarterly Cost of Revenue

47.62 Million

Accolade Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Accolade's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Accolade or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Accolade is way too risky over 90 days horizon
Accolade appears to be risky and price may revert if volatility continues
Accolade has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 336.02 M. Net Loss for the year was (417.24 M) with profit before overhead, payroll, taxes, and interest of 141 M.
Accolade currently holds about 335.63 M in cash with (65.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71.
Accolade has a frail financial position based on the latest SEC disclosures
Over 82.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.nasdaq.com: Exercise or conversion by Singh Rajeev of 17500 shares of Accolade subject to Rule 16b-3

Accolade Upcoming and Recent Events

Earnings reports are used by Accolade to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Accolade previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report4th of May 2022
Next Financial Report14th of July 2022
Next Fiscal Quarter End28th of February 2022
Next Fiscal Year End4th of May 2022
Last Quarter Report30th of November 2021
Last Financial Announcement28th of February 2021

Accolade Largest EPS Surprises

Earnings surprises can significantly impact Accolade's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-10-14
2020-08-31-0.4-0.47-0.0717 
2021-05-05
2021-02-28-0.1-0.22-0.12120 
2022-04-28
2022-02-28-0.36-0.51-0.1541 
View All Earnings Estimates

Accolade SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Accolade prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Accolade investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Accolade specific information freely available to individual and institutional investors to make a timely investment decision.
27th of July 2022
Submission of Matters to a Vote of Security Holders
View
21st of July 2022
Entry into a Material Definitive Agreement
View
30th of June 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
2nd of May 2022
Other Events
View
28th of April 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
14th of February 2022
Unclassified Corporate Event
View
9th of February 2022
Unclassified Corporate Event
View
4th of February 2022
Unclassified Corporate Event
View

Accolade Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 781.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Accolade's market, we take the total number of its shares issued and multiply it by Accolade's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Accolade Profitablity

Accolade's profitability indicators refer to fundamental financial ratios that showcase Accolade's ability to generate income relative to its revenue or operating costs. If, let's say, Accolade is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Accolade's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Accolade's profitability requires more research than a typical breakdown of Accolade's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (124.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (52.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.52.
Last ReportedProjected for 2022
Return on Average Assets(0.10) (0.11) 
Return on Average Equity(0.17) (0.18) 
Return on Invested Capital(0.62) (0.64) 
Return on Sales(0.41) (0.44) 

Management Efficiency

The entity has return on total asset (ROA) of (11.92) % which means that it has lost $11.92 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (85.89) %, meaning that it created substantial loss on money invested by shareholders. Accolade management efficiency ratios could be used to measure how well accolade manages its routine affairs as well as how well it operates its assets and liabilities. As of August 13, 2022, Return on Average Assets is expected to decline to -0.11. In addition to that, Return on Average Equity is expected to decline to -0.18. Accolade Assets Non Current are projected to increase significantly based on the last few years of reporting. The past year's Assets Non Current were at 876.39 Million. The current year Goodwill and Intangible Assets is expected to grow to about 887.5 M, whereas Return on Average Assets are forecasted to decline to (0.11) .
Last ReportedProjected for 2022
Book Value per Share 13.41  14.47 
Enterprise Value over EBIT(9.00) (9.71) 
Enterprise Value over EBITDA(13.43) (14.49) 
Price to Book Value 1.41  1.45 
Tangible Assets Book Value per Share 7.25  9.83 
Enterprise Value1.1 B1.3 B
Tangible Asset Value462.9 M372.6 M

Technical Drivers

As of the 13th of August 2022, Accolade shows the risk adjusted performance of 0.27, and Mean Deviation of 5.33. Accolade technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for Accolade, which can be compared to its rivals. Please confirm Accolade mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and information ratio to decide if Accolade is priced correctly, providing market reflects its regular price of 12.91 per share. Given that Accolade has jensen alpha of 1.28, we suggest you to validate Accolade's prevailing market performance to make sure the company can sustain itself at a future point.

Accolade Price Movement Analysis

The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Simple Moving Average indicator is calculated by adding the closing price of Accolade for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Accolade short-term fluctuations and highlight longer-term trends or cycles.
.

Accolade Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Accolade insiders, such as employees or executives, is commonly permitted as long as it does not rely on Accolade's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Accolade insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Neff Thomas J over a week ago via Macroaxis 
Exercise or conversion by Neff Thomas J of 413 shares of Accolade subject to Rule 16b-3
Kent Cindy over two weeks ago via Macroaxis 
Acquisition by Kent Cindy of 14060 shares of Accolade subject to Rule 16b-3
Brodsky Jeffrey S over two weeks ago via Macroaxis 
Exercise or conversion by Brodsky Jeffrey S of 2659 shares of Accolade subject to Rule 16b-3
Barnes Stephen H over three weeks ago via Macroaxis 
Exercise or conversion by Barnes Stephen H of 414 shares of Accolade subject to Rule 16b-3
Barnes Stephen H over three weeks ago via Macroaxis 
Exercise or conversion by Barnes Stephen H of 414 shares of Accolade subject to Rule 16b-3
Neff Thomas J over a month ago via Macroaxis 
Exercise or conversion by Neff Thomas J of 417 shares of Accolade subject to Rule 16b-3
Barnes Stephen H over a month ago via Macroaxis 
Acquisition by Barnes Stephen H of 27720 shares of Accolade subject to Rule 16b-3
Barnes Stephen H over a month ago via Macroaxis 
Exercise or conversion by Barnes Stephen H of 4975 shares of Accolade subject to Rule 16b-3
Brodsky Jeffrey S over two months ago via Macroaxis 
Exercise or conversion by Brodsky Jeffrey S of 1207 shares of Accolade subject to Rule 16b-3
Brodsky Jeffrey S over two months ago via Macroaxis 
Exercise or conversion by Brodsky Jeffrey S of 1207 shares of Accolade subject to Rule 16b-3
Neff Thomas J over two months ago via Macroaxis 
Exercise or conversion by Neff Thomas J of 416 shares of Accolade subject to Rule 16b-3
Neff Thomas J over three months ago via Macroaxis 
Exercise or conversion by Neff Thomas J of 417 shares of Accolade subject to Rule 16b-3

Accolade Predictive Daily Indicators

Accolade intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Accolade stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Accolade Forecast Models

Accolade time-series forecasting models is one of many Accolade's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Accolade's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Accolade Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Accolade stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Accolade shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Accolade. By using and applying Accolade Stock analysis, traders can create a robust methodology for identifying Accolade entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(0.27) (0.29) 
Gross Margin 0.46  0.47 
Profit Margin(0.40) (0.43) 
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Accolade to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module
Please continue to Trending Equities. Note that the Accolade information on this page should be used as a complementary analysis to other Accolade's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Accolade Stock analysis

When running Accolade price analysis, check to measure Accolade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accolade is operating at the current time. Most of Accolade's value examination focuses on studying past and present price action to predict the probability of Accolade's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Accolade's price. Additionally, you may evaluate how the addition of Accolade to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Is Accolade's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
781.9 M
Quarterly Revenue Growth YOY
0.44
Return On Assets
-0.12
Return On Equity
-0.86
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine Accolade value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.